Varenicline (Chantix) warnings: risk versus benefit.
D001552:Benzazepines / Q000009:adverse effects*; D054333:Drug Partial Agonism; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced / Q000209:etiology*; D018722:Nicotinic Agonists / Q000009:adverse effects*; D011810:Quinoxalines / Q000009:adverse effects*; D018570:Risk Assessment; D012307:Risk Factors; D016540:Smoking Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000188:drug therapy* / Q000523:psychology; D016896:Treatment Outcome; D000068580:Varenicline
D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline